http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002155160-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2002-06-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4003822039e82671082965e017290c54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f359a346f317b80aa3fb46a71cb68cd |
| publicationDate | 2002-10-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002155160-A1 |
| titleOfInvention | Microencapsulated plasminogen activators |
| abstract | A drug delivery system which includes a plurality of microcapsules, each microcapsule containing a plasminogen activator entrapped in a biocompatible, biodegradable, substantially water-soluble polymeric matrix such that the plasminogen activator is releasable therefrom upon exposure of the microcapsules to an aqueous environment, as well as methods for preparing same. Methods of treating a thrombotic condition and reducing the time required for reperfusion of an occluded blood vessel are also described, which include parenterally administering to a mammal a therapeutically effective amount of a pharmaceutical composition which includes a plurality of such microcapsules. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011129526-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9314499-B2 |
| priorityDate | 1999-06-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 76 of 76.